Inventor · disambiguated record
Allan K. Uldam
Also filed as: ULDAM ALLAN K · ULDAM ALLAN KJAERSGAARD
19 granted patents·9 pending applications·598 citations·filing 2001–2021
97Inventor score
Top patents by PatentIndex Score
28 records- 0198US8921393B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 30, 2014·41 cites·36 claims
- 0297US10028944B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2017·Granted Jul 24, 2018·15 cites·15 claims
- 0397US9566271B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 0497US8377959B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2012·Granted Feb 19, 2013·26 cites·12 claims
- 0597US8008323B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 30, 2011·25 cites·9 claims
- 0697US7994193B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 9, 2011·29 cites·9 claims
- 0797US7732462B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Jun 8, 2010·36 cites·24 claims
- 0897US7659285B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Feb 9, 2010·33 cites·11 claims
- 0997US7601740B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·26 claims
- 1096US10525046B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2018·Granted Jan 7, 2020·12 cites·20 claims
- 1196US9211289B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2014·Granted Dec 15, 2015·20 cites·13 claims
- 1296US7713995B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted May 11, 2010·30 cites·15 claims
- 1396US6815458B2Azacyclic compoundsACADIA PHARM INC·Filed 2001·Granted Nov 9, 2004·85 cites·48 claims
- 1496US6756393B2Azacyclic compoundsACADIA PHARM INC·Filed 2003·Granted Jun 29, 2004·77 cites·5 claims
- 1595US9296694B2Azacyclic compoundsACADIA PHARM INC·Filed 2015·Granted Mar 29, 2016·17 cites·4 claims
- 1694US8227487B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesWEINER DAVID M·Filed 2011·Granted Jul 24, 2012·25 cites·12 claims
- 1788US9765053B2Methods of treatment using selective 5-HT2A inverse agonistsANDERSSON CARL-MAGNUS A·Filed 2011·Granted Sep 19, 2017·12 cites·5 claims
- 1886US6627645B2Muscarinic agonistsACADIA PHARM INC·Filed 2001·Granted Sep 30, 2003·25 cites·65 claims
- 1981US2022241265A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2079US2024091212A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2178US2020323836A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2019·Application pending·0 cites
- 2277US7238713B2Muscarinic agonistsACADIA PHARM INC·Filed 2003·Granted Jul 3, 2007·13 cites·16 claims
- 2368US2009186921A1Azacyclic compoundsACADIA PHARM INC·Filed 2009·Application pending·0 cites
- 2461US2016237036A1Azacyclic compoundsACADIA PHARM INC·Filed 2016·Application pending·0 cites
- 2559US2005014757A1Azacyclic compoundsFiled 2004·Application pending·0 cites
- 2658US2006194778A1Azacyclic compoundsANDERSSON CARL-MAGNUS A·Filed 2006·Application pending·0 cites
- 2758US2006194834A1Azacyclic compoundsANDERSSON CARL-MAGNUS A·Filed 2006·Application pending·0 cites
- 2856US2007155795A1Muscarinic agonistsACADIA PHARM INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allan K. Uldam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →